Hong-Gang Wang

27PUBLICATIONS
56CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targetsCell development, proliferation and death
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Aug 20, 2026
Inhibiting PIK3C3/VPS34 enhances anti-GD2 immunotherapy in neuroblastoma.

|Jul 07, 2026
VPS37A loss creates CASP8-dependent vulnerability via the MAP3K7-NF-κB-CFLAR axis.

|May 13, 2026
Establishment of Patient-Derived Organoids for Pediatric Cancer Research.

|Apr 24, 2026
Targeting VPS4 elicits STING-driven anti-tumor immunity to suppress rhabdomyosarcoma growth.

|Apr 17, 2026
Cutting edge: ESCRT-mediated phagophore closure in mammals.

|Feb 20, 2025
Physiological insights into ESCRT-mediated phagophore closure: potential cytoprotective roles for ATG8ylated membranes.

Kouta Hamamoto, Xinwen Liang, David M Opozda

Pageof 5

Frequent Collaborators

11 joint publications

Yoshinori Takahashi

6 joint publications

Fang Tian

4 joint publications

Kouta Hamamoto

3 joint publications

David M Opozda